Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
31/10/2025
The onshore Chinese yuan against the US dollar closed at 7.1098 at 03:00 Beijing time, down 105 points from Wednesday night's close. The trading volume was $52.979 billion.
Latest
3 m ago
Why is the central bank studying and implementing policy measures to support the repair of individuals' credit? What impact will this have?
7 m ago
In September, South Korea's leading economic index increased by 0.1 percent compared to the previous month.
8 m ago
In September, South Korea's industrial production increased by 11.6% year on year, exceeding the forecast of a 5.9% rise.
8 m ago
Change in USD Bonds | Sunac China's SUNAC 5.25 09/30/26 price increased by 1.885% to 15.261.
9 m ago
Creat Group-B(06628) partner Inhibrx announced positive results from the Phase II clinical trial of ozekibart in the treatment of chondrosarcoma, and plans to submit the BLA performance progress in 2026.
See all latest